Teva Pharmaceuticals Hit With A Slew Of Downgrades Following Guidance Revision
Did George Soros Sell His Stake In Israeli-Based SodaStream Because Of Political Reasons?
Teva Pharmaceuticals Hit With A Slew Of Downgrades Following Guidance Revision
Did George Soros Sell His Stake In Israeli-Based SodaStream Because Of Political Reasons?
Market Wrap For April 16: Markets Hold On To Gains On Positive Yellen Comments And Economic Data
Market Wrap For April 8: Markets Bounce Higher As Earnings Season Begins
Market Wrap For April 16: Markets Hold On To Gains On Positive Yellen Comments And Economic Data
Market Wrap For April 8: Markets Bounce Higher As Earnings Season Begins
Market Wrap For April 7: Bears In Complete Control As Markets Get Hammered Yet Again
Market Wrap For April 4: Dow Suffers Triple Digit Point Loss, Nasdaq Continues To Underperform
TEVA PHARMACEUTICALS Recent News
Market Wrap For April 1: S&P 500 Hitting New All-Time High Not An April Fools' Joke
Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy
Market Wrap For March 28: Markets Still Positive Despite Giving Up Early Gains
Market Wrap For March 19: Yellen Hints of Higher Rates & Sooner Than Expected End To Taper
Market Wrap For March 14: Ukraine Tension Drag Markets Lower
Market Wrap For March 12: Nasdaq Ends Losing Streak, Dow Mildly Lower
Market Wrap For March 4: Bulls Take Over As Ukraine Fears Dissipate
Market Wrap For February 21: Markets End The Week On A Negative Note
Market Wrap For February 10: Markets Cautious Ahead Of Yellen Testimony
Market Wrap For January 29: Markets Lower on Fed Taper, Emerging Markets Worries
Market Wrap For January 23: Chinese Data, Mixed Earnings Spooking Investors
Market Wrap For January 2: Markets Begin 2014 on Negative Note
Market Wrap For December 27: Markets Quiet Before Weekend
Illumina and Other Bargain Biotech Stocks Worth a Look Now
Amgen Earnings Preview: Strong Earnings Growth Expected
Seven Hot Indian Stocks
Top Performing Health Care Stocks in January
Lazard Upgrades Cubist Pharmaceuticals To Buy, $33 PT
Needham Raises PT On Cubist Pharmaceuticals To $33
Deutsche Bank Reports On Procter & Gamble Partnership With Teva Pharmaceuticals
Teva Pharma (TEVA) - A History of Takeovers